Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia
Bone Marrow Transplantation, Published online: 07 November 2019; doi:10.1038/s41409-019-0742-7Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia
Source: Bone Marrow Transplantation - Category: Hematology Authors: Mauricette Michallet Peter Dreger Mohamad Sobh Linda Koster Jennifer Hoek Ariane Boumendil Christof Scheid Christopher P. Fox Gerald Wulf William Kr üger Michel van Gelder Paolo Corradini Domenico Russo Jakob Passweg H élène Schoemans Wolfgang Bethge N Source Type: research
More News: Bone Marrow Transplant | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia | Transplants